Kinnevik AB (publ) - Q2 2022 holdings

$176 Million is the total value of Kinnevik AB (publ)'s 2 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
TDOC  Teladoc Health, Inc.$122,335,000
-54.0%
3,683,6680.0%69.48%
+25.4%
 Babylon Holdings Ltd$53,734,000
-74.9%
54,942,5680.0%30.52%
-31.5%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-08
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Babylon Holdings Ltd6Q1 202344.6%
Teladoc Health, Inc.5Q4 202278.3%
Recursion Pharmaceuticals, Inc.4Q3 2023100.0%

View Kinnevik AB (publ)'s complete holdings history.

Latest significant ownerships (13-D/G)
Kinnevik AB (publ) Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
RECURSION PHARMACEUTICALS, INC.May 22, 202310,405,6685.6%
Babylon Holdings LtdNovember 14, 2022115,433,52218.6%
Teladoc Health, Inc.April 15, 20217,491,1244.9%
Livongo Health, Inc.Sold outNovember 03, 202000.0%
MILLICOM INTERNATIONAL CELLULAR SASold outJanuary 21, 202000.0%

View Kinnevik AB (publ)'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-02
13F-HR2023-10-06
13F-HR2023-07-25
SC 13G2023-05-22
13F-HR2023-04-14
13F-HR2023-02-01
32022-12-30
SC 13D2022-11-14
13F-HR2022-10-25
13F-HR2022-08-08

View Kinnevik AB (publ)'s complete filings history.

Compare quarters

Export Kinnevik AB (publ)'s holdings